We previously demonstrated that the 1-year TB risk in RA patients receiving TNF-α inhibitors was higher than that found among patients receiving non-TNF-α inhibitors in a nationwide population-based study between 2008 and 2012 [23]. Here, TNF is linked to tuberculosis.